1. A roadmap for clinical trial design in marginal zone lymphoma. Issue 11 (12th September 2022) Authors: Alderuccio, Juan Pablo; Habermann, Thomas; Kuker, Russ; Moskowitz, Craig H.; Zelenetz, Andrew D.; Lossos, Izidore S. Journal: American journal of hematology Issue: Volume 97:Issue 11(2022) Page Start: 1398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Issue 3 (March 2015) Authors: Illidge, Tim; Bouabdallah, Reda; Chen, Robert; Gopal, Ajay K.; Moskowitz, Craig H.; Ramchandren, Radhakrishnan; Shustov, Andrei R.; Tilly, Herve; Trippett, Tanya M.; Gibb, Adam; Grove, Laurie E.; Advani, Ranjana Journal: Leukemia & lymphoma Issue: Volume 56:Issue 3(2015:Mar.) Page Start: 703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide. Issue 2 (February 2015) Authors: Welch, Mary R.; Sauter, Craig S.; Matasar, Matthew J.; Faivre, Geraldine; Weaver, Susan A.; Moskowitz, Craig H.; Omuro, Antonio M. Journal: Leukemia & lymphoma Issue: Volume 56:Issue 2(2015:Feb.) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin Lymphoma. Issue 5 (10th February 2021) Authors: Alencar, Alvaro J.; Moskowitz, Craig H. Journal: Journal of clinical oncology Issue: Volume 39:Issue 5(2021) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma. Issue 20 (10th July 2021) Authors: Kumar, Anita; Casulo, Carla; Advani, Ranjana H.; Budde, Elizabeth; Barr, Paul M.; Batlevi, Connie L.; Caron, Philip; Constine, Louis S.; Dandapani, Savita V.; Drill, Esther; Drullinsky, Pamela; Friedberg, Jonathan W.; Grieve, Clare; Hamilton, Audrey; Hamlin, Paul A.; Hoppe, Richard T.; Horwitz, S... Journal: Journal of clinical oncology Issue: Volume 39:Issue 20(2021) Page Start: 2257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B‐cell lymphoma in the rituximab era. (12th October 2015) Authors: Kumar, Anita; Lunning, Matthew A.; Zhang, Zhigang; Migliacci, Jocelyn C.; Moskowitz, Craig H.; Zelenetz, Andrew D. Journal: British journal of haematology Issue: Volume 171:Number 5(2015:Dec.) Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel agents may positively impact chemotherapy and transplantation in subsets of diffuse large B-cell lymphoma. Issue 6 (3rd June 2019) Authors: Dahi, Parastoo B.; Moskowitz, Craig H.; Giralt, Sergio A.; Lazarus, Hillard M. Journal: Expert review of hematology Issue: Volume 12:Issue 6(2019) Page Start: 407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Novel agents positively impact chemotherapy and transplantation in Hodgkin lymphoma. Issue 4 (3rd April 2019) Authors: Dahi, Parastoo B.; Moskowitz, Craig H.; Giralt, Sergio A.; Lazarus, Hillard M. Journal: Expert review of hematology Issue: Volume 12:Issue 4(2019) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience. Issue 8 (3rd August 2018) Authors: Giulino-Roth, Lisa; O'Donohue, Tara; Chen, Zhengming; Trippett, Tanya M.; Klein, Elizabeth; Kernan, Nancy A.; Kobos, Rachel; Prockop, Susan E.; Scaradavou, Andromachi; Shukla, Neerav; Steinherz, Peter G.; Moskowitz, Alison J.; Moskowitz, Craig H.; Boulad, Farid Journal: Leukemia & lymphoma Issue: Volume 59:Issue 8(2018) Page Start: 1861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outcomes of primary refractory diffuse large B‐cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era. (16th December 2016) Authors: Vardhana, Santosha A.; Sauter, Craig S.; Matasar, Matthew J.; Zelenetz, Andrew D.; Galasso, Natasha; Woo, Kaitlin M.; Zhang, Zhigang; Moskowitz, Craig H. Journal: British journal of haematology Issue: Volume 176:Number 4(2017) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗